Frontiers | Emergence of Intrahepatic Cholangiocarcinoma: How High-Throughput Technologies Expedite the Solutions for a Rare Cancer Type | Genetics
Incorporating FGFR Inhibitors into the Treatment Paradigm for Cholangiocarcinoma: Current Concepts and Future Directions - CCA News Online | CCA News Online
Frontiers | Fibroblast Growth Factor Receptor 1-4 Genetic Aberrations as Clinically Relevant Biomarkers in Squamous Cell Lung Cancer | Oncology
Cholangiocarcinoma With FGFR Genetic Aberrations: A Unique Clinical Phenotype | JCO Precision Oncology
FGFR2 genomic aberrations: Achilles heel in the management of advanced cholangiocarcinoma - Cancer Treatment Reviews
Schematic representation of commonly found FGFR2 fusion proteins in... | Download Scientific Diagram
Cholangiocarcinoma With FGFR Genetic Aberrations: A Unique Clinical Phenotype | JCO Precision Oncology
Targeting FGFR inhibition in cholangiocarcinoma - Cancer Treatment Reviews
Cholangiocarcinoma With FGFR Genetic Aberrations: A Unique Clinical Phenotype | JCO Precision Oncology
Novel Therapies Targeting FGFR-Altered Advanced Cholangiocarcinoma
Cholangiocarcinoma With FGFR Genetic Aberrations: A Unique Clinical Phenotype | JCO Precision Oncology
Clinical trials of FGF/FGFR signaling-targeted therapies for CCA. | Download Scientific Diagram
Cholangiocarcinoma With FGFR Genetic Aberrations: A Unique Clinical Phenotype | JCO Precision Oncology
Advances and challenges in targeting FGFR signalling in cancer | Nature Reviews Cancer
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma | British Journal of Cancer
Frontiers | Fibroblast Growth Factor Receptor 1-4 Genetic Aberrations as Clinically Relevant Biomarkers in Squamous Cell Lung Cancer | Oncology
IJMS | Free Full-Text | FGFR Fusions in Cancer: From Diagnostic Approaches to Therapeutic Intervention | HTML
Genomic alterations in cholangiocarcinoma: clinical significance and relevance to therapy
Cholangiocarcinoma | Nature Reviews Disease Primers
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma | British Journal of Cancer
Novel Therapies Targeting FGFR-Altered Advanced Cholangiocarcinoma
Cholangiocarcinoma With FGFR Genetic Aberrations: A Unique Clinical Phenotype | JCO Precision Oncology
